SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

NAUT

Nautilus Biotechnology, Inc.
NASDAQHealth Care

Latest close: 2.06 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Sep 11, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Jul 28, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
  3. Jul 28, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record30221 flagged findings
Reported transactions (Form 4)61since Mar 1, 2024
Corporate events (8-K)17since Aug 12, 2020

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-04-28share offering or dilution eventrecentOpen filing ↗
    “…sales, or the perception in the market that the holders of a large number of shares intend to sell shares, could reduce the market…”
    +1 more passage from the same document
    • “…reduce the market price of our Common Stock. Pursuant to the Amended and Restated Registration Rights and Lock-Up Agreement (the…”
  • 2026-04-28listing compliance noticerecentOpen filing ↗
    “…in the potential loss of confidence by investors and employees. On May 1, 2025, we received a letter from the Listing Qualifications…”
    +1 more passage from the same document
    • “…us that since the Company’s stock had achieved a closing bid price of greater than $1.00 for at least 10 consecutive business days,…”
  • 2026-04-28export control restrictionsrecentOpen filing ↗
    “…risks occurs, it could require us to dedicate significant resources to remedy such occurrence, and if we are unsuccessful in…”
  • 2026-04-28capital return (buybacks/dividends)recentOpen filing ↗
    “…market” equity offering program under our Sales Agreement with TD Cowen or our Shelf Registration Statement, our stockholders will…”
  • 2026-04-28Department of Justice inquiryrecentOpen filing ↗
    “…Act, which contains a private right of action. These new state laws will require ongoing compliance efforts and investment. In…”
  • 2026-02-26share offering or dilution eventrecentOpen filing ↗
    “…with Legacy Nautilus as the surviving company in the Merger and, after giving effect to such Merger, Legacy Nautilus becoming…”
    +1 more passage from the same document
    • “…company in the Merger and, after giving effect to such Merger, Legacy Nautilus becoming a wholly-owned subsidiary of New…”
  • 2026-02-26listing compliance noticerecentOpen filing ↗
    “…in the potential loss of confidence by investors and employees. On May 1, 2025, we received a letter from the Listing Qualifications…”
    +1 more passage from the same document
    • “…us that since the Company’s stock had achieved a closing bid price of greater than $1.00 for at least 10 consecutive business days,…”
  • 2026-02-26export control restrictionsrecentOpen filing ↗
    “…risks occurs, it could require us to dedicate significant resources to remedy such occurrence, and if we are unsuccessful in…”

2 older entries not shown

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 302)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Sep 18, 26424B5 ↗Securities offering
  • Sep 11, 268-K ↗Current report · A material agreement was terminated
  • Sep 11, 26S-3 ↗Securities offering
  • Sep 11, 26SCHEDULE 13D/A ↗Stake with intent to influence · Marc L. Andreessen · 4.9% · event on Sep 9, 26 · amendment
  • Aug 28, 26SCHEDULE 13D/A ↗Stake with intent to influence · Marc L. Andreessen · 6.0% · event on Aug 26, 26 · amendment
  • Aug 14, 26SCHEDULE 13D/A ↗Stake with intent to influence · Perceptive Advisors LLC · 9.1% · event on Jun 30, 26 · amendment
  • Jul 28, 2610-Q ↗Quarterly report
  • Jul 28, 268-K ↗Current report · Results
  • Jun 30, 26SCHEDULE 13D/A ↗Stake with intent to influence · Marc L. Andreessen · 7.1% · event on Jun 26, 26 · amendment
  • Insider transaction · 5 Form 4 filingsshow all 5hide
  • Jun 18, 268-K ↗Current report · Shareholder vote results
  • Jun 4, 26SCHEDULE 13D/A ↗Stake with intent to influence · Marc L. Andreessen · 9.9% · event on Jun 2, 26 · amendment
  • Jun 4, 26Form 4 ↗Insider transaction
  • Apr 28, 26DEFA14A ↗Shareholder meeting and votes
  • Apr 28, 26DEF 14A ↗Shareholder meeting and votes
  • Apr 28, 2610-Q ↗Quarterly report
  • Apr 28, 268-K ↗Current report · Results
  • Insider transaction · 2 Form 4 filingsshow all 2hide
  • Mar 4, 26SCHEDULE 13D/A ↗Stake with intent to influence · Parag Mallick · 17.6% · event on Mar 2, 26 · amendment
  • Mar 4, 26Form 4 ↗Insider transaction

302 filings on record, the oldest from May 14, 20.

Listing the 25 most recent filings of the 302 on record.

8-Ks, explained

Stress1Structure9Governance7
  • Sep 11, 26StructureA material agreement was terminated+2 more in the same filing8-K 1.02 ↗
  • May 2, 25StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Feb 27, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Jan 31, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Feb 28, 24StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Nov 1, 22GovernanceA senior executive left or was appointed8-K/A 5.02 ↗
  • Mar 31, 22GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Jun 10, 21StructureCompleted an acquisition or disposal+8 more in the same filing8-K 2.01 ↗
  • Feb 8, 21StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Aug 12, 20StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • Parag Mallick17.6%Mar 2, 26SCHEDULE 13D/A ↗1 earlier filing
  • Sujal Patel16.3%Mar 2, 26SCHEDULE 13D/A ↗1 earlier filing
  • Perceptive Advisors LLC9.1%Jun 30, 26SCHEDULE 13D/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
  • Marc L. Andreessen4.9%Sep 9, 26SCHEDULE 13D/A ↗6 co-filers on this document — the figure is the largest single stake, not their sum. · 3 earlier filings

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Jun 2, 26Sell$10.8MAH Equity Partners Bio II, L.L.C.↗
  • Jun 2, 26Sell$902KAH Equity Partners Bio II, L.L.C.↗
  • Mar 4, 26Buy$65KSujal M PatelCEO, President, and Secretary↗
  • Nov 6, 25Buy$6KKentaro SuzukiChief Marketing Officer↗
  • Sep 8, 25Buy$57KSujal M PatelCEO, President, and Secretary↗
  • Sep 5, 25Buy$79KSujal M PatelCEO, President, and Secretary↗
  • Sep 4, 25Buy$13KMatthew B. MurphyGeneral Counsel↗
  • May 29, 25Buy$11KAnna MowryCFO and Treasurer↗
  • May 12, 25Buy$1KParag MallickChief Scientist↗
  • May 8, 25Buy$9KParag MallickChief Scientist↗
  • Mar 20, 25Buy$24KSujal M PatelCEO, President, and Secretary↗
  • Mar 19, 25Buy$53KSujal M PatelCEO, President, and Secretary↗

There are 7 more transactions in this stretch.

Stock compensation, tax and giftsshow the 2 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Sep 23, 24Compensation$22KMary E. GodwinSenior VP, Operations↗
  • Sep 17, 24Compensation$16KMary E. GodwinSenior VP, Operations↗

The full record holds 21 transactions and goes back to Feb 27, 23.

Its sector and its market

Nautilus Biotechnology, Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Nautilus Biotechnology, Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Nautilus Biotechnology, Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
302 documents on file, from May 14, 2020 to Sep 18, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.

Nautilus Biotechnology, Inc. (NAUT): stock price history, insider trades and SEC filings — HornScout